These results suggest that CA acts to suppress NASH by diverse, interconnected mechanisms, namely, stimulating antioxidants, suppressing lipogenesis and fat accumulation, and upregulating Bcl2, which accounts for its secondary inhibitory effects on inflammation and apoptosis. The gene discussed is BCL2; the disease is metabolic dysfunction-associated steatohepatitis.